Acelyrin Inc
(SLRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 316,258 | 422,064 | 69,179 | 41,794 |
| Operating Income | -316,258 | -422,064 | -69,179 | -41,794 |
| Other Income | 68,032 | 40,423 | 4,407 | -45 |
| Pre-tax Income | -248,226 | -381,641 | -64,772 | -41,839 |
| Net Income Continuous | -248,226 | -381,641 | -64,772 | -41,839 |
| Net Income | $-248,226 | $-381,641 | $-64,772 | $-41,839 |
| EPS Basic Total Ops | -2.50 | -5.43 | -41.59 | -60.87 |
| EPS Basic Continuous Ops | -2.50 | -5.43 | -41.59 | -60.87 |
| EPS Diluted Total Ops | -2.50 | -5.43 | -41.59 | -60.87 |
| EPS Diluted Continuous Ops | -2.50 | -5.43 | -41.59 | -60.87 |
| EPS Diluted Before Non-Recurring Items | -2.50 | -5.43 | N/A | N/A |
| EBITDA(a) | $-334,248 | $-432,444 | $-69,425 | $-41,794 |